A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
This study has been completed.
Study NCT00002176
Information provided by Bristol-Myers Squibb
First Received: November 2, 1999
Last Updated: October 1, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
